Pivotal Therapeutics Inc. (Pivotal) is a specialty pharmaceutical company. The Company specializes in cardiovascular science, focused on cardiovascular disease and overall health. Its lead prescription only medical food product, VASCAZEN, is used for the clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, Eicosapentaenoic Acid EPA) and Docosahexanenoic Acid (DHA) levels. VASCAZEN is a pharmaceutical formulation of EPA:DHA. Pivotal's OMAZEN is being commercialized in Canada for the maintenance of good health through elevating Omega- 3 fatty acid levels and Benefishial, which is targeting the direct to consumer market place and consists of six different products.